Caroline E. Rutten

Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Liesbeth C. de Wreede et al. · Journal of Clinical Investigation · 2017 · 99 citations · Full text

Histocompatibility, Cell Therapy, T Cell Reactivity +18

High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning

Cornelis A.M. van Bergen, Caroline E. Rutten, Edith D. van der Meijden et al. · Cancer Research · 2010 · 85 citations · Full text

Histocompatibility, Hla, Immunology +23

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg‐Witte et al. · JAMA Oncology · 2022 · 81 citations · Full text

Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity

Marieke Griffioen, Edith D. van der Meijden, Elisabeth H. Slager et al. · Proceedings of the National Academy of Sciences · 2008 · 67 citations · Full text

Histocompatibility, Cell Therapy, Hla Immunogenetics +18

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Sabine Haggenburg, Birgit I. Lissenberg‐Witte, Rob van Binnendijk et al. · Blood Advances · 2022 · 62 citations · Full text

Immunohematology, Immunodeficiencies, Hematology Patients +22